MAKE WAY FOR THE FIRST ACTIVE HEMOSTATIC POWDER

MAKE WAY FOR THE FIRST ACTIVE HEMOSTATIC POWDER

NEWS AND EVENTS

September 12, 2017

Biom’up announces the filing of its Document de base within the framework of its planned IPO on the Euronext Paris regulated market Saint-Priest, France, September 12, 2017 – Biom’Up, specialist of surgical hemostasis, announces that it filed its Document de base (source document) with the Autorité des Marchés Financiers (AMF,…

READ

From 10th to 12th October 2017 – EUROPHARMAT

We are happy to annouce you that we will participate to Europharmat congress from 10th to 12th October in Saint Malo. Booth #92 EUROPHARMAT / Palais des Congrès le Grand Large / Saint Malo

READ

December 20, 2016

Biom’up receives CE Mark Approval for HEMOBLAST™ Bellows, the first active hemostatic powder for management of mild to moderate intra-operative bleedings Lyon (France), December 7th, 2016 Biom’up announces today that it has received CE Marking for HEMOBLAST™ Bellows active hemostatic powder and delivery system. HEMOBLAST™ Bellows is indicated in open…

READ

Legal Information: HEMOBLAST™ Bellows - Implantable Medical device Class III for surgery reserved for use by qualified healthcare professionals, reimbursement depends on each country.
Read the instructions for use on the packaging carefully before use. CE0086: BSI - Manufacturer: Biom’up SA France.